Andrea Alms Video: Money in Motion 160 - Pharma Q1 2025 Revenue Decline
TRANSCRIPT: Hello, my name is Andrea Alms. I'm a technology investor and financial manager and this is your money in motion. After fourth quarter 2024, in which revenues boomed throughout the biopharma industry, there were reversals for several drug makers. In Q1, which is the first three months of 2025. The companies that took the biggest hits were in the US, where there is considerable angst in the industry over ta